Bacterial Toxins and Toxoids from List Labs

List Labs has a portfolio of over 100 research reagents comprising bacterial toxins, toxoids, GMP Lipopolysaccharides, FRET peptides, and vaccine-carrying proteins and adjuvants. These products meet the needs of researchers, scientists, and organizations studying mechanisms of infection and disease and immune response to develop novel approaches to therapeutics and vaccines.

Company Background

List Biological Laboratories Inc. is a global leader with over 45 years of experience in bacterial-derived products. The company developed and manufactured one of the first Live Biotherapeutic Products to enter clinical trials. List Labs offers unparalleled microbiome-derived drug development experience, resulting in an impressive track record of successful collaborations with clients for cGMP manufacturing and a catalog of over 100 bacterial products used in medical research and vaccine development worldwide.

Expertise and Capabilities

Headquartered in Campbell, CA, List Labs offers world-class expertise in drug product development, including bacterial fermentation, protein purification, process development, analytical development, scale-up, and development of robust cGMP manufacturing processes for drug products used in clinical trials.

List Labs Products

List Labs produces a variety of bacterial toxins and other products, including C. difficile toxin A and toxin B, shiga toxins, cholera toxin, anthrax toxins (PA, LF, and EF), pertussis toxin, diphtheria toxin, diphtheria CRM197, and tetanus toxin. They also offer several types of lipopolysaccharides (LPS) or endotoxin for purchase by the research community. These products are available in stock formats and volumes or can be produced in custom volumes to meet clients’ needs.

Top Product Families

• Pertussis Toxin
• Lipopolysaccharides
• Cholera Toxin
• Diphtheria Toxin
• Tetanus Toxin
• FRET Peptide Substrates for Botulinum Toxin